DOI:
10.1055/s-00000045
Der Nuklearmediziner
LinksClose Window
References
Hofman MS, Emmet L, Kaur S. et al.
TheraP: A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versus cabazitaxel in metastatic castration resistant.
J Clin Oncol 2020
38.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.